Healthcare provider profile · identity verified

Christa S Mclaughlin, MD

Family Practice · DAVENPORT, IA · NPI 1780680272

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	643	146
Losartan Potassium	Losartan Potassium	554	153
Atorvastatin Calcium	Atorvastatin Calcium	458	132
Amlodipine Besylate	Amlodipine Besylate	389	102
Simvastatin	Simvastatin	315	84
Omeprazole	Omeprazole	308	93
Lisinopril	Lisinopril	277	80
Rosuvastatin Calcium	Rosuvastatin Calcium	267	80
Metoprolol Succinate	Metoprolol Succinate	252	70
Sertraline Hcl	Sertraline Hcl	221	68
Furosemide	Furosemide	193	59
Duloxetine Hcl	Duloxetine Hcl	187	52
Hydrochlorothiazide	Hydrochlorothiazide	187	60
Alprazolam	Alprazolam	185	50
Escitalopram Oxalate	Escitalopram Oxalate	167	43
Trazodone Hcl	Trazodone Hcl	167	49
Bupropion Xl	Bupropion Hcl	144	37
Tramadol Hcl	Tramadol Hcl	138	38
Metformin Hcl Er	Metformin Hcl	134	36
Albuterol Sulfate Hfa	Albuterol Sulfate	123	38
Meloxicam	Meloxicam	121	38
Metformin Hcl	Metformin Hcl	120	29
Pravastatin Sodium	Pravastatin Sodium	120	32
Ozempic	Semaglutide	117	29
Pantoprazole Sodium	Pantoprazole Sodium	116	37
Metoprolol Tartrate	Metoprolol Tartrate	104	31
Gabapentin	Gabapentin	102	36
Fluoxetine Hcl	Fluoxetine Hcl	99	29
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	93	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	85	22
Potassium Chloride	Potassium Chloride	83	25
Mounjaro	Tirzepatide	72	16
Fluticasone Propionate	Fluticasone Propionate	67	27
Lorazepam	Lorazepam	67	24
Solifenacin Succinate	Solifenacin Succinate	67	20
Alendronate Sodium	Alendronate Sodium	66	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	65	15
Clonazepam	Clonazepam	64	13
Prednisone	Prednisone	64	52
Amitriptyline Hcl	Amitriptyline Hcl	57	16
Synthroid	Levothyroxine Sodium	52	13
Eliquis	Apixaban	51	15
Tamsulosin Hcl	Tamsulosin Hcl	51	13
Ropinirole Hcl	Ropinirole Hcl	46	11
Triamcinolone Acetonide	Triamcinolone Acetonide	43	30
Venlafaxine Hcl Er	Venlafaxine Hcl	43	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	43	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	42	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	41	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	41	11
Allopurinol	Allopurinol	40	11
Famotidine	Famotidine	39	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	39	12
Verapamil Er	Verapamil Hcl	36	suppressed
Azithromycin	Azithromycin	33	30
Trulicity	Dulaglutide	33	suppressed
Celecoxib	Celecoxib	32	suppressed
Ventolin Hfa	Albuterol Sulfate	32	suppressed
Estradiol	Estradiol	30	12
Januvia	Sitagliptin Phosphate	30	suppressed
Atenolol	Atenolol	29	suppressed
Breo Ellipta	Fluticasone/Vilanterol	29	suppressed
Cephalexin	Cephalexin	29	25
Mirtazapine	Mirtazapine	29	suppressed
Ipratropium Bromide	Ipratropium Bromide	28	suppressed
Carvedilol	Carvedilol	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	13
Temazepam	Temazepam	26	suppressed
Cefdinir	Cefdinir	25	20
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Irbesartan	Irbesartan	25	suppressed
Symbicort	Budesonide/Formoterol Fumarate	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	22
Myrbetriq	Mirabegron	24	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	23	suppressed
Propranolol Hcl	Propranolol Hcl	23	suppressed
Spiriva Handihaler	Tiotropium Bromide	23	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Humalog Kwikpen U-100	Insulin Lispro	22	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	21	suppressed
Clopidogrel	Clopidogrel Bisulfate	21	suppressed
Ondansetron Odt	Ondansetron	21	19
Topiramate	Topiramate	21	suppressed
Midodrine Hcl	Midodrine Hcl	20	suppressed
Glipizide Er	Glipizide	19	suppressed
Montelukast Sodium	Montelukast Sodium	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	18
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Indapamide	Indapamide	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Glimepiride	Glimepiride	16	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Sildenafil Citrate	Sildenafil Citrate	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Spiriva Respimat	Tiotropium Bromide	15	suppressed
Amoxicillin	Amoxicillin	14	12
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Euthyrox	Levothyroxine Sodium	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Hydrocortisone	Hydrocortisone	14	11
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Colestipol Hcl	Colestipol Hcl	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Fluconazole	Fluconazole	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Cefuroxime	Cefuroxime Axetil	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Estradiol (Once Weekly)	Estradiol	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Nystatin	Nystatin	11	suppressed
Spironolactone	Spironolactone	11	suppressed
Tirosint-Sol	Levothyroxine Sodium	11	suppressed
Tradjenta	Linagliptin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error